Tenelia Triple Combination Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
After a screening, a 2-week, single-blind placebo run-in, 200 patients will be randomized in a 1 : 1 ratio to the addition of either once-daily Teneligliptin 20mg or sitagliptin 100mg to ongoing stable doses of glimepiride in combination with metformin for 24 weeks.
Epistemonikos ID: 5343a31ed346ad0a12b73135f55113ac11c6c580
First added on: May 12, 2024